免疫逃逸的人类岛屿类器官改善糖尿病
Eiji Yoshihara1,2,3, Carolyn O'Connor4, Emanuel Gasser1
1Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA.
Nature
|August 21, 2020
概括
来自干细胞的人类岛屿类器官 (HILO) 显示出糖尿病治疗的前景. 在糖尿病小鼠中,WNT4信号驱动成熟,PD-L1表达使免疫规避成功移植.
科学领域:
- 干细胞生物学
- 内分泌学
- 免疫学
背景情况:
- 干细胞衍生小岛为胰岛素依赖性糖尿病治疗提供了潜力.
- 在实现功能成熟和免疫兼容方面仍然存在挑战.
研究的目的:
- 从诱导的多能干细胞产生功能性人体岛屿类器官 (HILO).
- 研究WNT4信号在HILO代谢成熟中的作用.
- 在糖尿病模型中评估HILO的治疗潜力和免疫规避策略.
主要方法:
- 从诱导的多能干细胞生成HILO.
- 评估葡萄糖刺激的胰岛素分泌和代谢成熟.
- 将HILO移植到糖尿病小鼠模型中 (NOD/SCID和免疫能力).
- 对编程死亡配体1 (PD-L1) 过度表达和干扰素γ刺激进行免疫规避的评估.
主要成果:
- 确定非正规的WNT4信号对于HILO的代谢成熟至关重要.
- 在糖尿病小鼠中,功能成熟的HILO在移植后迅速恢复葡萄糖平衡.
- 在具有免疫能力的小鼠中,PD- L1 保护的HILO 异位细胞过度表达50天.
- 干扰素-γ诱导PD-L1,限制T细胞激活,并防止移植的排斥.
结论:
- 可以从干细胞产生对葡萄糖敏感的HILO,表现出强大的胰岛素分泌.
- PD-L1表达是一种可行的策略,以克服HILO异种移植的免疫排斥.
- 对于目前的糖尿病疗法来说, HILO 是一个有前途的,
相关概念视频
Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75


